Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells.

Yang YF, Lee YC, Wang YY, Wang CH, Hou MF, Yuan SF.

Kaohsiung J Med Sci. 2019 Apr 18. doi: 10.1002/kjm2.12075. [Epub ahead of print]


Essential Role of Visfatin in Lipopolysaccharide and Colon Ascendens Stent Peritonitis-Induced Acute Lung Injury.

Lee YC, Lin CY, Chen YH, Chiu WC, Wang YY, Hsu C, Hu SC, Su YH, Yuan SF.

Int J Mol Sci. 2019 Apr 4;20(7). pii: E1678. doi: 10.3390/ijms20071678.


Influence of Tea Consumption on the Development of Second Esophageal Neoplasm in Patients with Head and Neck Cancer.

Wang YK, Chen WC, Lai YH, Chen YH, Wu MT, Kuo CT, Wang YY, Yuan SF, Liu YP, Wu IC.

Cancers (Basel). 2019 Mar 19;11(3). pii: E387. doi: 10.3390/cancers11030387.


Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients.

Huang CJ, Huang MY, Fang PT, Chen F, Wang YT, Chen CH, Yuan SS, Huang CM, Luo KH, Chuang HY, Wang YY, Lee HH.

Am J Clin Nutr. 2019 Mar 1;109(3):606-614. doi: 10.1093/ajcn/nqy329.


MAL-PDT inhibits oral precancerous cells and lesions via autophagic cell death.

Wang YY, Chen YK, Hu CS, Xiao LY, Huang WL, Chi TC, Cheng KH, Wang YM, Yuan SF.

Oral Dis. 2019 Apr;25(3):758-771. doi: 10.1111/odi.13036. Epub 2019 Feb 6.


Evaluation of the mRNA expression levels of integrins α3, α5, β1 and β6 as tumor biomarkers of oral squamous cell carcinoma.

Chang HW, Yen CY, Chen CH, Tsai JH, Tang JY, Chang YT, Kao YH, Wang YY, Yuan SF, Lee SY.

Oncol Lett. 2018 Oct;16(4):4773-4781. doi: 10.3892/ol.2018.9168. Epub 2018 Jul 18.


Overexpression of sprouty2 in human oral squamous cell carcinogenesis.

Liao PH, Wang YY, Wang WC, Chen CH, Kao YH, Hsu JW, Chen CY, Chen PH, Yuan SS, Chen YK.

Arch Oral Biol. 2018 Mar;87:131-142. doi: 10.1016/j.archoralbio.2017.12.021. Epub 2017 Dec 27.


CYT-Rx20 Inhibits Cervical Cancer Cell Growth and Migration Through Oxidative Stress-Induced DNA Damage, Cell Apoptosis, and Epithelial-to-Mesenchymal Transition Inhibition.

Wang YY, Hsieh PW, Chen YK, Hu SC, Hsu YL, Tsai CH, Yuan SF.

Int J Gynecol Cancer. 2017 Sep;27(7):1306-1317. doi: 10.1097/IGC.0000000000001033.


CYT-Rx20 inhibits ovarian cancer cells in vitro and in vivo through oxidative stress-induced DNA damage and cell apoptosis.

Wang YY, Chen YK, Hu SC, Hsu YL, Tsai CH, Chi TC, Huang WL, Hsieh PW, Yuan SF.

Cancer Chemother Pharmacol. 2017 Jun;79(6):1129-1140. doi: 10.1007/s00280-017-3330-9. Epub 2017 May 12.


Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies.

Hung CC, Chien CY, Chu PY, Wu YJ, Lin CS, Huang CJ, Chan LP, Wang YY, Yuan SF, Hour TC, Chen JY.

Head Neck. 2017 Aug;39(8):1621-1630. doi: 10.1002/hed.24803. Epub 2017 May 12.


Novel quantitative analysis of autofluorescence images for oral cancer screening.

Huang TT, Huang JS, Wang YY, Chen KC, Wong TY, Chen YC, Wu CW, Chan LP, Lin YC, Kao YH, Nioka S, Yuan SF, Chung PC.

Oral Oncol. 2017 May;68:20-26. doi: 10.1016/j.oraloncology.2017.03.003. Epub 2017 Mar 15.


Synthetic β-nitrostyrene derivative CYT-Rx20 as inhibitor of oral cancer cell proliferation and tumor growth through glutathione suppression and reactive oxygen species induction.

Wang YY, Chen YK, Hsu YL, Chiu WC, Tsai CH, Hu SC, Hsieh PW, Yuan SF.

Head Neck. 2017 Jun;39(6):1055-1064. doi: 10.1002/hed.24664. Epub 2017 Mar 27.


3'-Hydroxy-4'-methoxy-β-methyl-β-nitrostyrene inhibits tumor growth through ROS generation and GSH depletion in lung cancer cells.

Tsai CH, Hsieh PW, Lee YC, Wang CH, Chiu WC, Lu CW, Wang YY, Hu SC, Cheng TL, Yuan SF.

Life Sci. 2017 Mar 1;172:19-26. doi: 10.1016/j.lfs.2016.12.009. Epub 2016 Dec 20.


The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways.

Chiu WC, Lee YC, Su YH, Wang YY, Tsai CH, Hou YA, Wang CH, Huang YF, Huang CJ, Chou SH, Hsieh PW, Yuan SF.

PLoS One. 2016 Nov 22;11(11):e0166453. doi: 10.1371/journal.pone.0166453. eCollection 2016.


Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.

Er TK, Wang YY, Chen CC, Herreros-Villanueva M, Liu TC, Yuan SS.

Oral Dis. 2015 Oct;21(7):872-8. doi: 10.1111/odi.12357. Epub 2015 Aug 6.


Association study between novel CYP26 polymorphisms and the risk of betel quid-related malignant oral disorders.

Wu SJ, Chen YJ, Shieh TY, Chen CM, Wang YY, Lee KT, Lin YM, Chien PH, Chen PH.

ScientificWorldJournal. 2015;2015:160185. doi: 10.1155/2015/160185. Epub 2015 Mar 9.


Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.

Wang YY, Tail YH, Wang WC, Chen CY, Kao YH, Chen YK, Chen CH.

BMC Oral Health. 2014 Aug 5;14:99. doi: 10.1186/1472-6831-14-99.


Plasma polyunsaturated fatty acids and periodontal recovery in Taiwanese with periodontitis: a significant relationship.

Wang SH, Hung HC, Tsai CC, Huang MC, Ho KY, Wu YM, Wang YY, Lin YC.

Arch Oral Biol. 2014 Aug;59(8):800-7. doi: 10.1016/j.archoralbio.2014.04.009. Epub 2014 Apr 22.


Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.

Wang LH, Ting SC, Chen CH, Tsai CC, Lung O, Liu TC, Lee CW, Wang YY, Tsai CL, Lin YC.

J Oral Pathol Med. 2010 Feb;39(2):155-61. doi: 10.1111/j.1600-0714.2009.00873.x.


Supplemental Content

Loading ...
Support Center